NASDAQ:ADMS
Delisted
Adamas Pharmaceuticals Stock News
$8.22
+0 (+0%)
At Close: May 27, 2022
The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid
11:34am, Friday, 05'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 4) * Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN)
The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid
12:00am, Friday, 05'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 4)
Biohaven Pharmaceutical...
Adamas Pharmaceuticals, Inc. (ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that its
Adamas to Present at Upcoming William Blair Conference
08:01pm, Wednesday, 03'rd Jun 2020
EMERYVILLE, Calif., June 03, 2020 -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a clinically meaningful.
Quelles montres de luxe d’occasion acheter en ligne actuellement?
11:00am, Wednesday, 03'rd Jun 2020
SÉLECTION - Quelles montres signées de grandes marques voient leur cote progresser sur le Net? Le site spécialisé de vente en ligne Chrono 24 dresse le Top 5 de celles dont la valeur augmente.
Edited Transcript of ADMS earnings conference call or presentation 7-May-20 9:00pm GMT
02:04am, Thursday, 21'st May 2020
Q1 2020 Adamas Pharmaceuticals Inc Earnings Call
Adamas Pharmaceuticals, Inc. (ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it has be
Adamas announces issuance of new U.S. patent for GOCOVRI in Parkinson's disease - expands ...
12:00am, Wednesday, 13'th May 2020Adamas Announces New Employment Inducement Grant
10:46pm, Friday, 08'th May 2020
EMERYVILLE, Calif., May 08, 2020 -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted five.
